A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer - No Study Results Posted

A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer (FP253-GDEPT)

This study is currently recruiting participants.

Study NCT00625430 Information provided by Biotech Equity Partners Pty Ltd

First Received: February 20, 2008 Last Updated: January 9, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)